A type of drug used against ovarian and breast cancers could offer a brand new targeted approach for treating a range of cancers with particular genetic defects, including a common form of kidney cancer.

Chemotherapy halves the risk of a rare form of kidney cancer coming back after surgery, the largest ever trial conducted in the disease worldwide has found.

A magnetic resonance imaging test that measures the volume of blood in tumours could help select which patients will benefit from drugs that block blood vessel growth, a new study shows.